Development and validation of an HPLC method for the simultaneous determination of amlodipine, hydrochlorothiazide, and Valsartan in tablets of their novel triple combination and binary pharmaceutical associations

Journal of Liquid Chromatography and Related Technologies

Volumn 34, Issue 19, 2011, Pages 2383-2395

  Vignaduzzo, Silvana E ^a   Castellano, Patricia M ^a   Kaufman, Teodoro S ^a  

^a Universidad Nacional de Rosario   (Argentina)

Author keywords

Experimental design; HPLC DAD; HPLC UV; RP HPLC; Triple combination; Validation

Indexed keywords

HPLC-DAD; HPLC-UV; RP-HPLC; TRIPLE COMBINATION; VALIDATION;

CHEMICAL ANALYSIS; DESIGN OF EXPERIMENTS; LIQUID CHROMATOGRAPHY;

STATISTICS;

AMLODIPINE; HYDROCHLOROTHIAZIDE; VALSARTAN;

ARTICLE; DRUG DETERMINATION; DRUG STRUCTURE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; SENSITIVITY AND SPECIFICITY; TABLET FORMULATION;

EID: 84855898488     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826076.2011.591020     Document Type: Article

References (35)

1. Wagstaff, A. J. Valsartan/Hydrochlorothiazide: A Review of its Use in the Management of Hypertension. Drugs 2006, 66, 1881-1901. (Pubitemid 44596199)
2. Lacourciere, Y.; Poirier, L.; Hebert, D.; Assouline, L.; Stolt, P.; Rehel, B.; Khder, Y. Antihypertensive Efficacy and Tolerability of Two Fixed-Dose Combinations of Valsartan and Hydrochlorothiazide Compared with Valsartan Monotherapy in Patients with Stage 2 or 3 Systolic Hypertension: An 8-Week, Randomized, Double-Blind, Parallel-Group Trial. Clin. Ther. 2005, 27, 1013-1021. (Pubitemid 41262459)
3. Doménech, M.; Coca, A. Role of Triple Fixed Combination Valsartan, Amlodipine and Hydrochlorothiazide in Controlling Blood Pressure. Patient Pref. Adher. 2010, 4, 105-113.
4. Destro, M.; Cagnoni, F.; D'Ospina, A.; Ricci, A. R.; Demichele, E.; Peros, E.; Zaninelli, A.; Preti, P. Role of Valsartan, Amlodipine and Hydrochlorothiazide Fixed Combination in Blood Pressure Control: An Update. Vasc. Health Risk Manag. 2010, 6, 253-260.
5. Gradman, A. H. Rationale for Triple-Combination Therapy for Management of High Blood Pressure. J. Clin. Hypertens. 2010, 12, 869-878.
6. Sweetman, S. C. Martindale - The Complete Drug Reference, 36th edition; The Pharmaceutical Press: Chicago, USA, 2009.
7. Oparil, S.; Giles, T.; Ofili, E.; Pitt, B.; Seifu, Y.; Samuel, R.; Hilkert, R.; Sowers, J. In Triple Combination Therapy with Amlodipine/Valsartan/ HCTZ at Maximal Doses is Safe and Effective for Hypertensive Patients Uncontrolled on ARB Monotherapy: The EXTRA Study. 25th Annual Scientific Meeting of the American Society of Hypertension. New York, USA, May 1-4, 2010, Abstract OR-5.
8. Deeks, E. D. Amlodipine/Valsartan/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension. Am. J. Cardiovasc. Drugs 2009, 9, 411-418.
9. Bhad, P.; Ayalasomayajula, S.; Karan, R.; Leon, S.; Riviere, G.-J.; Sunkara, G.; Jarugula, V. Evaluation of Pharmacokinetic Interactions Between Amlodipine, Valsartan, and Hydrochlorothiazide in Patients With Hypertension. J. Clin. Pharmacol. 2011, 51, 933-942.
10. Calhoun, D. A.; Crikelair, N. A.; Yen, J.; Glazer, R. D. Amlodipine/Valsartan/Hydrochlorothiazide Triple Combination Therapy in Moderate/Severe Hypertension: Secondary Analyses Evaluating Efficacy and Safety. Adv. Ther. 2009, 26, 1012-1023.
11. Erk, N. Spectrophotometric Analysis of Valsartan and Hydrochlorothiazide. Anal. Lett. 2002, 35, 283-302. (Pubitemid 34151090)
12. Dinc, E.; Uslu, B.; Ozkan, S. A. Spectral Resolution of a Binary Mixture Containing Valsartan and Hydrochlorothiazide in Tablets by Ratio Spectra Derivative and Inverse Least-Squares Techniques. Anal. Lett. 2005, 37, 679-693. (Pubitemid 38452208)
13. Carlucci, G.; di Carlo, V.; Mazzeo, P. Simultaneous Determination of Valsartan and Hydrochlorothiazide in Tablets by High-Performance Liquid Chromatography. Anal. Lett. 2000, 33, 2491-2500.
14. Satana, E.; Altinay, S.; Goger, N. G.; Ozkan, S. A.; Senturk, Z. Simultaneous Determination of Valsartan and Hydrochlorothiazide in Tablets by First-Derivative Ultraviolet Spectrophotometry and LC. J. Pharm. Biomed. Anal. 2001, 25, 1009-1013. (Pubitemid 32488968)
15. Ivanovic, D.; Malenovic, A.; Jancic, B.; Medenica, M.; Maskovic, M. Monitoring of Impurity Level of Valsartan and Hydrochlorothiazide Employing an RP-HPLC Gradient Mode. J. Liq. Chromatogr. R. T. 2007, 30, 2879-2890. (Pubitemid 47341171)
16. Hillaert, S.; Van den Bossche, W. Simultaneous Determination of Hydrochlorothiazide and Several Angiotensin-II-Receptor Antagonists by Capillary Electrophoresis. J. Pharm. Biomed. Anal. 2003, 31, 329-339. (Pubitemid 36254815)
17. Dhaneshwar, S. R.; Patre, N. G.; Mahadik, M. V. Validated TLC Method for Simultaneous Quantitation of Amlodipine Besylate and Valsartan in Bulk Drug and Formulation. Chromatographia 2009, 69, 157-161.
18. Ramadan, N. K.; Mohamed, H. M.; Moustafa, A. A. Rapid and Highly Sensitive HPLC and TLC Methods for Quantitation of Amlodipine Besilate and Valsartan in Bulk Powder and in Pharmaceutical Dosage Forms and in Human Plasma. Anal. Lett. 2010, 43, 570-581.
19. Kul, D.; Dogan-Topal, B.; Kutucu, T.; Uslu, B.; Ozkan, S. A. High-Performance Liquid Chromatographic and First Derivative of the Ratio Spectrophotometric Determination of Amlodipine and Valsartan in Their Binary Mixtures. J. AOAC Int. 2010, 93, 882-890.
20. Chitlange, S. S.; Bagri, K.; Wankhede, S. B.; Sakarkar, D. N. Simultaneous Spectrophotometric Estimation of Amlodipine and Valsartan in Capsule Formulation. Orient. J. Chem. 2008, 24, 689-692.
21. Shaalan, R. A.; Belal, T. S. Simultaneous Spectrofluorimetric Determination of Amlodipine Besylate and Valsartan in Their Combined Tablets. Drug Test. Anal. 2010, 2, 489-493.
22. Celebier, M.; Altinöz, S.; Dinc, E. Fractional Wavelet Transform and Chemometric Calibrations for the Simultaneous Determination of Amlodipine and Valsartan in their Complex Mixture. In New Trends in Nanotechnology and Fractional Calculus Applications; Baleanu, D., Guvenc, Z. B., Tenreiro Machado, J. A., Eds.; Springer: The Netherlands, 2010; pp 333-340.
23. Kristoffersen, L.; Øiestad, E. L.; Opdal, M. S.; Krogh, M.; Lundanes, E.; Christophersen, A. S. Simultaneous Determination of 6 Beta-Blockers, 3 Calcium-Channel Antagonists, 4 Angiotensin-II Antagonists and 1 Antiarrhytmic Drug in Post-Mortem Whole Blood by Automated Solid Phase Extraction and Liquid Chromatography Mass Spectrometry: Method Development and Robustness Testing by Experimental Design. J. Chromatogr. B 2007, 850, 147-150.
24. Liu, F.; Zhang, J.; Xu, Y.; Gao, S.; Guo, Q. Simultaneous Determination of Hydrochlorothiazide and Valsartan in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry. Anal. Lett. 2008, 41, 1348-1365. (Pubitemid 351990072)
25. Shah, H. J.; Kataria, N. B.; Subbaiah, G.; Patel, C. N. Simultaneous LC-MS-MS Analysis of Valsartan and Hydrochlorothiazide in Human Plasma. Chromatographia 2009, 69, 1055-1060.
26. Li, H.; Wang, Y.; Jiang, Y.; Tang, Y.; Wang, J.; Zhao, L.; Gu, J. A Liquid Chromatography/Tandem Mass Spectrometry Method for the Simultaneous Quantification of Valsartan and Hydrochlorothiazide in Human Plasma. J. Chromatogr. B 2007, 852, 436-442. (Pubitemid 46830149)
27. Manish, B. N.; Jawaharlal, D. S.; Nivrutti, M. H.; Balkrishna, C. P. Validated RP-HPLC Method for Simultaneous Determination of Amlodipine Besylate and Hydrochlorothiazide from Pharmaceutical Preparation and Biological Samples. Res. J. Pharm. Tech. 2009, 2, 482-486.
28. Safeer, K.; Anbarasi, B.; Senthil Kumar, N. Analytical Method Development and Validation of Amlodipine and Hydrochlorothiazide in Combined Dosage Form by RP-HPLC. Int. J. Chem. Tech. Res. 2010, 2, 21-25.
29. Derringer, G. A Balancing Act: Optimizing a Product's Properties. Qual. Prog. 1994, 27, 51-58.
30. Wu, C. F. J.; Hamada, M. Experiments: Planning, Analysis, and Parameter Design Optimization, Wiley: New York, USA, 2000, p. 153-203.
31. Hund, E.; Vander Heyden, Y.; Massart, D. L. Smeyers-Verbeke, J. Derivation of System Suitability Test Limits From a Robustness Test on an LC Assay With Complex Antibiotic Samples. J. Pharm. Biomed. Anal. 2002, 30, 1197-1206. (Pubitemid 35284331)
32. Dejaegher, B.; Van der Heyden, T. Ruggedness and Robustness Testing. J Chromatogr. A 2007, 1158, 138-157. (Pubitemid 47021141)
33. Vander Heyden, Y.; Jimidar, M.; Hund, E.; Niemeijer, N.; Peeters, R.; Smeyers-Verbeke, J.; Massart, D. L.; Hoogmartens, J. Determination of System Suitability Limits with a Robustness Test. J. Chromatogr. A 1999, 845, 145-154. (Pubitemid 29313343)
34. ICH Guide Q2 (R1). Validation of Analytical Procedures-Text and Methodology. International Conference on Harmonization: Geneva, Switzerland, 2005.
35. Épshtein, N. A. Validation of HPLC Techniques for Pharmaceutical Analysis. Pharm. Chem. J. 2004, 38, 212-228. (Pubitemid 39162893)